Primary care monitoring of HbA1c tests in type 2 diabetic patients in Northern France and impact of the successive COVID-19 pandemic containments. Demoule, D. J., Quindroit, D. P., Frévent, D. C., Collins, P. D. C., Chazard, P. D. E., Beuscart, P. D. J., Berkhout, P. D. C., Calafiore, D. M., & Quersin, D. F. Diabetes Epidemiology and Management, 16:100233, October, 2024.
Primary care monitoring of HbA1c tests in type 2 diabetic patients in Northern France and impact of the successive COVID-19 pandemic containments [link]Paper  doi  abstract   bibtex   
Background French health authorities recommend the testing of HbA1c every 3 to 6 months in patients with diabetes. The successive containments linked to the SARSCoV-2 pandemic may have had a profound impact on the follow-up of diabetic patients in primary care. The objective of this study was to investigate the effect of containments on the volume of HbA1c assays and on HbA1c values of type 2 diabetic patients monitored in primary care in Northern France compared to usual seasonal variations. Methods Epidemiological study of a multicentre retrospective cohort, collecting the number and the value of HbA1c assays from type 2 diabetic patients, carried out in 73 private medical analysis laboratories in Northern France region between October 1, 2018 and October 31, 2022. Results A total of 196,744 patients and 828,037 tests were included. The first and third containments were associated with a significant decrease in the mean number of performed HbA1c tests, the decrease in the 2nd containment did not reach significance. We observed a significant decrease in HbA1c testing during the winter holiday season and the summer months. The variations in HbA1c values were not substantial compared to seasonal variations.
@article{demoule_primary_2024,
	title = {Primary care monitoring of {HbA1c} tests in type 2 diabetic patients in {Northern} {France} and impact of the successive {COVID}-19 pandemic containments},
	volume = {16},
	issn = {2666-9706},
	url = {https://www.sciencedirect.com/science/article/pii/S2666970624000386},
	doi = {10.1016/j.deman.2024.100233},
	abstract = {Background
French health authorities recommend the testing of HbA1c every 3 to 6 months in patients with diabetes. The successive containments linked to the SARSCoV-2 pandemic may have had a profound impact on the follow-up of diabetic patients in primary care. The objective of this study was to investigate the effect of containments on the volume of HbA1c assays and on HbA1c values of type 2 diabetic patients monitored in primary care in Northern France compared to usual seasonal variations.
Methods
Epidemiological study of a multicentre retrospective cohort, collecting the number and the value of HbA1c assays from type 2 diabetic patients, carried out in 73 private medical analysis laboratories in Northern France region between October 1, 2018 and October 31, 2022.
Results
A total of 196,744 patients and 828,037 tests were included. The first and third containments were associated with a significant decrease in the mean number of performed HbA1c tests, the decrease in the 2nd containment did not reach significance. We observed a significant decrease in HbA1c testing during the winter holiday season and the summer months. The variations in HbA1c values were not substantial compared to seasonal variations.},
	urldate = {2024-09-16},
	journal = {Diabetes Epidemiology and Management},
	author = {Demoule, Dr. Julie and Quindroit, Dr. Paul and Frévent, Dr. Camille and Collins, Prof. Dr. Claire and Chazard, Prof. Dr. Emmanuel and Beuscart, Prof. Dr. Jean-Baptiste and Berkhout, Prof. Dr. Christophe and Calafiore, Dr. Matthieu and Quersin, Dr. François},
	month = oct,
	year = {2024},
	keywords = {COVID-19, Diabetes mellitus, Disease management, Glycated hemoglobin, Primary health care, Type 2},
	pages = {100233},
}

Downloads: 0